TCL Archive Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs. April 14, 2006
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws November 20, 1992
